Out-licensing: Aloclair™ Rinse

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

For aphthous ulcers and other minor oral lesions

Aloclair rinse is indicated to relieve the pain caused by aphthous mouth ulcers and other minor oral lesions.
Aloclair rinse provides fast pain relief from chafing and irritation caused by braces and ill fitting dentures.

Registered

In the European Union, under the provisions of EEC Directive 93/42/EC Aloclair rinse is considered a Class 1 Medical Device.

In the U.S.A., Aloclair rinse is registered as a 510(k) OTC medical device.

Patents pending.

Marketing companies are required to sell Aloclair in key territories around the world.

Javier Boza
Global Business Development Director

Sinclair Pharmaceuticals

Sinclair Pharma plc, a rapidly growing UK based pharmaceutical company is seeking distributors around the world.

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.